BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9750508)

  • 1. [Diagnosis of organ-confined prostate cancer by systematic biopsy under guidance of TRUS].
    Gohji K; Fujii A
    Nihon Rinsho; 1998 Aug; 56(8):2062-6. PubMed ID: 9750508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transrectal ultrasound guided transperineal systematic prostate biopsy].
    Tanaka H; Shinkai M; Jo Y; Matsuki T
    Nihon Rinsho; 1998 Aug; 56(8):2067-71. PubMed ID: 9750509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The advance of ultrasound guided prostate biopsy--comparison between 4 quadrant and 6 sextant biopsy].
    Ishitoya S; Maeda H; Arai Y
    Nihon Rinsho; 1998 Aug; 56(8):2056-61. PubMed ID: 9750507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection.
    Frauscher F; Klauser A; Volgger H; Halpern EJ; Pallwein L; Steiner H; Schuster A; Horninger W; Rogatsch H; Bartsch G
    J Urol; 2002 Apr; 167(4):1648-52. PubMed ID: 11912381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of ultrasound-guided prostate biopsy in the diagnosis and treatment of localized prostate cancer].
    Ogawa O; Shichiri Y; Ohnishi H; Yoshida O
    Hinyokika Kiyo; 1996 Oct; 42(10):805-10. PubMed ID: 8951479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?
    Chen DJ; Falzarano SM; McKenney JK; Przybycin CG; Reynolds JP; Roma A; Jones JS; Stephenson A; Klein E; Magi-Galluzzi C
    BJU Int; 2015 Aug; 116(2):220-9. PubMed ID: 25060664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis.
    Cupp MR; Bostwick DG; Myers RP; Oesterling JE
    J Urol; 1995 May; 153(5):1543-8. PubMed ID: 7714976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing prostate biopsy cores based on volume vs the sextant biopsy: a prospective randomized controlled clinical study on cancer detection rates and morbidity.
    Mariappan P; Chong WL; Sundram M; Mohamed SR
    BJU Int; 2004 Aug; 94(3):307-10. PubMed ID: 15291857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens.
    Park EA; Lee HJ; Kim KG; Kim SH; Lee SE; Choe GY
    Int J Urol; 2007 Aug; 14(8):704-8. PubMed ID: 17681059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Length of prostate biopsy cores: does it impact cancer detection?
    Fiset PO; Aprikian A; Brimo F
    Can J Urol; 2013 Aug; 20(4):6848-53. PubMed ID: 23930611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of transrectal ultrasound scan of the prostate with sector biopsies for 323 New Zealand men with suspicion of prostate cancer.
    Smart R
    N Z Med J; 1999 Dec; 112(1101):465-9. PubMed ID: 10678211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional sampling of dorsal apex on systematic prostate biopsy: impact on early detection of prostate cancer.
    Miyake H; Harada K; Inoue TA; Takenaka A; Hara I; Fujisawa M
    Urology; 2007 Apr; 69(4):738-42. PubMed ID: 17445661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of transrectal needle biopsy of the prostate: usefulness of systematic 12 core biopsy].
    Imazu T; Yokoyama S; Fukuhara S; Hara T; Yamaguchi S; Adachi S
    Hinyokika Kiyo; 2007 Jun; 53(6):365-8. PubMed ID: 17628932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transrectal ultrasonography for the detection and staging of carcinoma of the prostate.
    Smith JA
    J Clin Ultrasound; 1996 Oct; 24(8):455-61. PubMed ID: 8884522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
    Sciarra A; Panebianco V; Cattarino S; Busetto GM; De Berardinis E; Ciccariello M; Gentile V; Salciccia S
    BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective study to reduce prostate biopsy cores by a real time interactive tool.
    Testoni N; Speciale N; Bertaccini A; Marchiori D; Fiorentino M; Manferrari F; Schiavina R; Cividini R; Galluzzo F; Maggio S; Biagi E; Masotti L; Masetti G; Martorana G
    Arch Ital Urol Androl; 2010 Dec; 82(4):238-41. PubMed ID: 21341571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic scheme.
    Scattoni V; Raber M; Capitanio U; Abdollah F; Roscigno M; Angiolilli D; Maccagnano C; Gallina A; SaccĂ  A; Freschi M; Doglioni C; Rigatti P; Montorsi F
    Eur Urol; 2011 Oct; 60(4):834-41. PubMed ID: 21820797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Image visibility of cancer to enhance targeting precision and spatial mapping biopsy for focal therapy of prostate cancer.
    Ukimura O; de Castro Abreu AL; Gill IS; Shoji S; Hung AJ; Bahn D
    BJU Int; 2013 Jun; 111(8):E354-64. PubMed ID: 23714647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.